Viewing Study NCT02846766


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-01-09 @ 5:00 PM
Study NCT ID: NCT02846766
Status: WITHDRAWN
Last Update Posted: 2018-08-02
First Post: 2016-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling
Sponsor: Teresa Helsten, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module